Allergen Immunotherapy Dosing Schedule
Yes, immunotherapy doses are typically increased weekly during the build-up phase, with 1-2 injections per week being the standard protocol to reach maintenance dose. 1, 2
Standard Build-Up Phase Protocol
The build-up phase of allergen immunotherapy follows a structured approach:
- Frequency: 1-2 injections per week is the conventional schedule 1, 2
- Starting dose: Usually begins at 1:1,000 or 1:10,000 dilution of the maintenance concentration 1
- Progression: Doses gradually increase until reaching maintenance level
- Duration: With this weekly schedule, patients typically reach maintenance dose in 3-6 months 1
Dose Adjustment Considerations
Several factors influence the rate of dose increases:
- Patient sensitivity: More cautious increases for highly sensitive patients 1
- Prior reactions: History of reactions may necessitate slower progression 1
- Concentration being delivered: Smaller percentage increases at higher concentrations 1
- Seasonal exposure: Consider not increasing or even reducing doses during high allergen exposure seasons 1
Alternative Accelerated Schedules
For patients needing to reach maintenance dose more quickly, alternative schedules exist:
Cluster immunotherapy:
Rush immunotherapy:
Safety Considerations
- Systemic reactions: After a systemic reaction, the dose is typically reduced to a previously tolerated level 1
- Missed doses: Dose reduction is necessary when the interval between injections is prolonged 1
- Seasonal adjustments: Consider not increasing or reducing doses during peak allergen seasons 1
Clinical Pearls
- Premedication (typically antihistamines) is strongly recommended before cluster or rush protocols to reduce systemic reaction risk 1
- Venom immunotherapy rush protocols have not shown the same high incidence of systemic reactions as inhalant allergen rush protocols 1
- The most common systemic reaction during rush protocols is flushing 1
- Weekly schedules are considered the safest approach for most patients 1
The weekly build-up schedule remains the most widely used approach due to its favorable safety profile while still providing effective desensitization for most patients.